doi: 10.1007/s11064-023-03934-8 41 ChenYLuoXYinYThomasERLiuKWangWet al
E., and Konrad, T
" We are encouraged by the potential of Soliqua 100/33, which has demonstrated superior HbA1c lowering versus Lantus ," said Peter Guenter, Executive Vice President, Head, Global Diabetes & Cardiovascular Business Unit, Sanofi
GLP-1 medications are marketed to help you lose weight, but one may be better at it than the rest, according to a new meta-analysis from the University of Georgia
The New England Journal of Medicine , 384 (11), 9891002.
Heres commentary from Lily management: There's no doubt in my mind, Geoff in five years, as I said, we're going to have a lot more data and we're going to see these drugs as foundational medical treatment for many chronic diseases, and with outcomes to hard outcomes data that moves the cost curve in populations. And eventually the Venn diagram of seniors who have obesity or overweight and other conditions, diabetes, of course already we have access in many plans there, but we'll be adding to that pie
